The prothrombin time testing market is expected to grow at a 5% CAGR during the forecast period, reaching a market share of US$ 10.38 billion in 2032, up from US$ 6.07 billion in 2021, owing to increased public awareness about the benefits and effectiveness of these devices in detecting blood disorders. FMI, in its upcoming …